Astec Lifesciences (NSE:ASTEC) Beneish M-Score: -1.89 (As of Jun. 25, 2026)


NSE:ASTEC Astec Lifesciences Ltd NSE:ASTEC
75 GF Score
Price ₹725.45
GF Value ₹976.08
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Astec Lifesciences Beneish M-Score?

Astec Lifesciences NSE:ASTEC -3.52% 75 Beneish M-Score is -1.89 as of Jun. 25, 2026. GuruFocus rates NSE:ASTEC with a GF Score™ of 75/100 and a GF Value™ of ₹976.08 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 246 Agriculture companies, Astec Lifesciences ranks worse than 69.92% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -1.89 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Astec Lifesciences's Beneish M-Score or its related term are showing as below:

NSE:ASTEC' s Beneish M-Score Range Over the Past 10 Years
Min: -3.22   Med: -2.35   Max: -1.89
Current: -1.89

During the past 13 years, the highest Beneish M-Score of Astec Lifesciences was -1.89. The lowest was -3.22. And the median was -2.35.


Astec Lifesciences Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Astec Lifesciences's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astec Lifesciences Beneish M-Score Chart

Astec Lifesciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.90 -2.88 -2.35 -3.22 -1.89

Astec Lifesciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.22 0.00 0.00 0.00 -1.89

NSE:ASTEC vs CTVA, CF: Beneish M-Score Comparison

For the Agricultural Inputs subindustry, Astec Lifesciences's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Astec Lifesciences Beneish M-Score vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Astec Lifesciences's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Astec Lifesciences's Beneish M-Score falls into.


NSE:ASTEC
75GF Score
Astec Lifesciences Ltd NSE:ASTEC
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Astec Lifesciences Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Astec Lifesciences for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.4173+0.528 * 0.6622+0.404 * 0.9941+0.892 * 1.1753+0.115 * 0.8964
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0+4.679 * -0.000223-0.327 * 0.7967
=-1.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ₹2,503 Mil.
Revenue was ₹4,481 Mil.
Gross Profit was ₹1,497 Mil.
Total Current Assets was ₹4,430 Mil.
Total Assets was ₹9,420 Mil.
Property, Plant and Equipment(Net PPE) was ₹4,538 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹449 Mil.
Selling, General, & Admin. Expense(SGA) was ₹0 Mil.
Total Current Liabilities was ₹4,998 Mil.
Long-Term Debt & Capital Lease Obligation was ₹500 Mil.
Net Income was ₹-809 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹-807 Mil.
Total Receivables was ₹1,503 Mil.
Revenue was ₹3,813 Mil.
Gross Profit was ₹844 Mil.
Total Current Assets was ₹3,411 Mil.
Total Assets was ₹8,814 Mil.
Property, Plant and Equipment(Net PPE) was ₹4,977 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹437 Mil.
Selling, General, & Admin. Expense(SGA) was ₹124 Mil.
Total Current Liabilities was ₹3,657 Mil.
Long-Term Debt & Capital Lease Obligation was ₹2,800 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2503.28 / 4481.456) / (1502.798 / 3813.035)
=0.558586 / 0.394121
=1.4173

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(843.674 / 3813.035) / (1497.311 / 4481.456)
=0.22126 / 0.334113
=0.6622

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (4429.911 + 4538.268) / 9420.382) / (1 - (3411.378 + 4977.25) / 8814.238)
=0.048003 / 0.048287
=0.9941

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=4481.456 / 3813.035
=1.1753

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(437.145 / (437.145 + 4977.25)) / (449.218 / (449.218 + 4538.268))
=0.080738 / 0.090069
=0.8964

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 4481.456) / (123.731 / 3813.035)
=0 / 0.032449
=0

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((500 + 4997.864) / 9420.382) / ((2800 + 3657.126) / 8814.238)
=0.583614 / 0.732579
=0.7967

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-809.175 - 0 - -807.075) / 9420.382
=-0.000223

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Astec Lifesciences has a M-score of -1.89 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -1.89 mean?
Astec Lifesciences (NSE:ASTEC) has a Beneish M-Score of -1.89 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Astec Lifesciences and its competitors. According to the industry distribution chart, Astec Lifesciences ranks #172 out of 246 companies in the Agriculture industry, placing it in the top 69.9%.
Is Astec Lifesciences' Beneish M-Score too high?
Astec Lifesciences' current Beneish M-Score is -1.89. Based on the distribution chart, Astec Lifesciences ranks #172 out of 246 companies in the Agriculture industry, which is below the industry midpoint. Overall, Astec Lifesciences has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astec Lifesciences' Beneish M-Score compare to CTVA and CF?
According to the Agriculture industry distribution chart, Astec Lifesciences ranks #172 out of 246 companies for Beneish M-Score. This places Astec Lifesciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for an Agriculture company?
A good Beneish M-Score depends on the Agriculture industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Astec Lifesciences and its competitors. Astec Lifesciences's current Beneish M-Score is -1.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astec Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Astec Lifesciences (NSE:ASTEC) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹976.08, compared to a current price of ₹725.45 — trading 25.7% below its estimated fair value. The current Beneish M-Score is -1.89. Astec Lifesciences' overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Astec Lifesciences (NSE:ASTEC), the current Beneish M-Score is -1.89 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astec Lifesciences (NSE:ASTEC) Overvalued in 2026?

Based on GuruFocus' analysis, Astec Lifesciences stock appears to be undervalued. The current stock price of ₹725.45 is trading 25.7% below its estimated GF Value™ of ₹976.08. GuruFocus considers Astec Lifesciences to be Modestly Undervalued.

Key valuation signals for NSE:ASTEC:

  • Beneish M-Score: -1.89
  • GF Value™: ₹976.08 vs. price of ₹725.45 (25.7% below fair value)
  • GF Score™: 75/100 with 4 warning signs

No single metric tells the full story. See the NSE:ASTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Astec Lifesciences Business Description

Other Exchanges 533138:India
Address Eastern Express Highway, Godrej One, 3rd Floor, Pirojshanagar, Vikhroli (East), Mumbai, MH, IND, 400 079
Astec Lifesciences Ltd manufactures & distributes a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company's products include agrochemicals, such as Triazole Fungicides, Herbicides, and Insecticides. The company is also into Intermediates & Specialty chemicals. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.
75GF Score

Get the complete analysis for NSE:ASTEC

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹725.45
Price
₹976.08
GF Value